ProfileGDS4132 / 241869_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 50% 51% 26% 30% 44% 51% 45% 40% 32% 34% 32% 43% 34% 32% 29% 34% 40% 37% 31% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101135.10150
GSM201543Muscle PCOS pioglitazone 121130.551
GSM201544Muscle PCOS pioglitazone 16164.620526
GSM201545Muscle PCOS pioglitazone 20182.657130
GSM201829Muscle PCOS pioglitazone 231122.92144
GSM201830Muscle PCOS pioglitazon 251142.04851
GSM201831Muscle PCOS pioglitazone 271119.10545
GSM201832Muscle PCOS pioglitazone 31103.86140
GSM201833Muscle PCOS pioglitazone 4176.041432
GSM201834Muscle PCOS pioglitazone 8184.691834
GSM201835Muscle PCOS after pioglitazone 10265.359632
GSM201836Muscle PCOS after pioglitazone 122102.35443
GSM201837Muscle PCOS after pioglitazone 16271.90434
GSM201838Muscle PCOS after pioglitazone 20270.826932
GSM201839Muscle PCOS after pioglitazone 23263.365729
GSM201840Muscle PCOS after pioglitazone 25282.75434
GSM201841Muscle PCOS after pioglitazone 27288.056340
GSM201842Muscle PCOS after pioglitazone 3277.750837
GSM201843Muscle PCOS after pioglitazone 4275.370131
GSM201844Muscle PCOS after pioglitazone 8292.008938